The AstraZeneca PLC ADR AZN slumped 0.66% to $78.38 Friday, on what proved to be an all-around mixed trading session for the ...

AstraZeneca PLC AZN shares inched down 0.99% to £117.80 Friday, on what proved to be an all-around rough trading session for ...

FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist ...

(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. The Cambridge, England-based biopharmaceutical company ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...

Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...

AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...